Meropenem/vaborbactam
Y. Vivian Tsai, Pharm.D.
,
Edina Avdic, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Complicated urinary tract infections
(cUTIs), including
pyelonephritis,
caused by susceptible
E. coli
,
K. pneumoniae
,
and
Enterobacter cloacae
species complex in adult patients (≥18 years of age)
[11]
[15]
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Invasive infections caused by susceptible KPC-producing
Enterobacterales
[1]
[10]
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.